Versican Secreted by Cancer-Associated Fibroblasts is a Poor Prognostic Factor in Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Versican Secreted by Cancer-Associated Fibroblasts is a Poor Prognostic Factor in Hepatocellular Carcinoma

Published:2022-05-11 Issue:11 Volume:29 Page:7135-7146
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Kato Koichi,Fukai Moto,Hatanaka Kanako C.,Takasawa Akira,Aoyama Tomoyuki,Hayasaka Takahiro,Matsuno Yoshihiro,Kamiyama Toshiya,Hatanaka Yutaka,Taketomi Akinobu^ORCID

Funder

Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-022-11862-0.pdf

Reference35 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

2. European Association for the Study of the Liver. Electronic address EEE, European Association for the Study of the L. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.

3. Ioannou GN, Green PK, Berry K. HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma. J Hepatol. 2018;68:25–32.

4. Said A, Ghufran A. Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma. World J Clin Oncol. 2017;8(6):429–36.

5. Kamiyama T, Nakanishi K, Yokoo H, et al. Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization. Ann Surg Oncol. 2009;16(6):1560–71.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Splicing variants of versican in CD133+/CD44+ prostate cancer stem cells;Pathology - Research and Practice;2024-08

2. Targets of tumor microenvironment for potential drug development;MedComm – Oncology;2024-03

3. Cancer-associated fibroblast-derived stanniocalcin 1 promotes cholangiocarcinoma progression and lymph node metastasis;Fundamental Research;2024-02

4. Prediction of CAF-related genes in immunotherapy and drug sensitivity in hepatocellular carcinoma: a multi-database analysis;Genes & Immunity;2024-01-17

5. Cancer-associated fibroblasts in neoadjuvant setting for solid cancers;Critical Reviews in Oncology/Hematology;2024-01